Search Articles

View query in Help articles search

Search Results (1 to 10 of 899 Results)

Download search results: CSV END BibTex RIS


Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study

Mobile Therapeutic Attention for Treatment-Resistant Schizophrenia (m-RESIST) Solution for Improving Clinical and Functional Outcomes in Treatment-Resistant Schizophrenia: Prospective, Multicenter Efficacy Study

A recent study with patients with a diagnosis of schizophrenia (N=361), randomized to receive either Slow Mo, a blended digital therapy targeting reasoning, or usual care, found also no significant difference between groups on the primary outcomes related to paranoia (the Green et al [77] Paranoid Thoughts Scale) at the primary end point at 24 weeks [33].

Jussi Seppälä, Eva Grasa, Anna Alonso-Solis, Alexandra Roldan-Bejarano, Marianne Haapea, Matti Isohanni, Jouko Miettunen, Johanna Caro Mendivelso, Cari Almazán, Katya Rubinstein, Asaf Caspi, Zolt Unoka, Kinga Farkas, Elisenda Reixach, Jesus Berdun, Judith Usall, Susana Ochoa, Iluminada Corripio, Erika Jääskeläinen, m-Resist Group

JMIR Hum Factors 2025;12:e67659